Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,000 | 7 | 62.9% |
| Travel and Lodging | $4,253 | 16 | 17.8% |
| Consulting Fee | $2,672 | 1 | 11.2% |
| Food and Beverage | $1,855 | 92 | 7.8% |
| Education | $79.86 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19,885 | 31 | $0 (2024) |
| Olympus Corporation of the Americas | $2,816 | 20 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $188.50 | 26 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $158.25 | 3 | $0 (2023) |
| Insmed, Inc. | $110.58 | 6 | $0 (2024) |
| Mylan Specialty L.P. | $102.57 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $85.91 | 5 | $0 (2024) |
| Grifols USA, LLC | $78.79 | 6 | $0 (2022) |
| GlaxoSmithKline, LLC. | $71.34 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $55.70 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $529.35 | 22 | Boehringer Ingelheim Pharmaceuticals, Inc. ($110.68) |
| 2023 | $456.67 | 12 | Regeneron Healthcare Solutions, Inc. ($158.25) |
| 2022 | $64.28 | 4 | Insmed, Inc. ($32.48) |
| 2021 | $84.18 | 6 | Grifols USA, LLC ($51.70) |
| 2019 | $11,960 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,807) |
| 2018 | $9,233 | 32 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,818) |
| 2017 | $1,532 | 17 | Olympus Corporation of the Americas ($1,463) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: Medical Device | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | 3B Medical, Inc. | LUNA (Device) | Food and Beverage | Cash or cash equivalent | $29.04 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 07/25/2024 | Pinnacle Biologics, Inc | Photofrin (Drug) | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: Oncology | ||||||
| 06/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/28/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $33.10 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: PULMONOLOGY | ||||||
| 04/23/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Infectious Diseases | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $39.30 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Respiratory | ||||||
| 02/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: RESPIRATORY | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Respiratory | ||||||
| 12/11/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PAH | ||||||
| 12/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $88.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/03/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: HFCWO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 734 | 849 | $191,392 | $50,592 |
| 2022 | 10 | 435 | 467 | $101,927 | $29,793 |
| 2021 | 10 | 617 | 712 | $49,838 | $24,466 |
| 2020 | 10 | 572 | 655 | $46,788 | $20,372 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 135 | $44,415 | $12,093 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 53 | $23,479 | $7,238 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 92 | $20,516 | $6,519 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $23,547 | $5,979 | 25.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 115 | 130 | $22,100 | $5,779 | 26.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 114 | 128 | $21,888 | $5,548 | 25.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 90 | 107 | $11,877 | $2,352 | 19.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 55 | 55 | $10,340 | $1,732 | 16.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $6,909 | $1,620 | 23.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 28 | 31 | $3,255 | $827.10 | 25.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 27 | 28 | $1,680 | $556.64 | 33.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 22 | 22 | $1,386 | $349.58 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 80 | $26,320 | $8,405 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $19,539 | $4,937 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 29 | $12,847 | $4,273 | 33.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 50 | 51 | $8,670 | $2,504 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 26 | $3,702 | $1,665 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 21 | $4,683 | $1,457 | 31.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $4,935 | $1,283 | 26.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 26 | 26 | $4,446 | $1,203 | 27.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 35 | 36 | $6,768 | $1,164 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 27 | 30 | $2,334 | $1,058 | 45.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 23 | 24 | $3,288 | $857.83 | 26.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 22 | 22 | $2,442 | $496.10 | 20.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 25 | 25 | $752.50 | $157.74 | 21.0% |
About Dr. Mohammad Alsumrain, M.D
Dr. Mohammad Alsumrain, M.D is a Pulmonary Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1639327885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Alsumrain, M.D has received a total of $23,859 in payments from pharmaceutical and medical device companies, with $529.35 received in 2024. These payments were reported across 121 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,000).
As a Medicare-enrolled provider, Alsumrain has provided services to 2,358 Medicare beneficiaries, totaling 2,683 services with total Medicare billing of $125,223. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Austin, TX
- Active Since 08/29/2008
- Last Updated 06/27/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639327885
Products in Payments
- OFEV (Drug) $13,030
- EVIS EXERA (Device) $1,463
- Olympus Capital Accessories (Device) $657.35
- Olympus EBUS Bronchoscopes (Device) $400.23
- Olympus EMR & ESD Devices (Device) $294.80
- DUPIXENT (Biological) $173.32
- LONHALA MAGNAIR (Drug) $119.93
- Arikayce (Drug) $110.58
- YUPELRI (Drug) $83.77
- Prolastin-C Liquid (Biological) $78.79
- TEZSPIRE (Biological) $73.82
- TRELEGY ELLIPTA (Drug) $71.34
- UTIBRON (Drug) $68.57
- Cresemba (Drug) $55.70
- TYVASO (Drug) $42.63
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $33.10
- LUNA (Device) $29.04
- DIFICID (Drug) $28.77
- ENTRESTO (Drug) $25.80
- Photofrin (Drug) $24.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Austin
Dr. William Bartek, M.d, M.D
Pulmonary Disease — Payments: $277,754
John Hinze, D.o, D.O
Pulmonary Disease — Payments: $63,477
Dr. Mehdi Mirsaeidi, M.d, M.D
Pulmonary Disease — Payments: $54,206
Dr. Subramaniyam Rajan, M.d, M.D
Pulmonary Disease — Payments: $48,598
Edward Ortiz, M.d, M.D
Pulmonary Disease — Payments: $30,048
Ernest Lawrence, M.d, M.D
Pulmonary Disease — Payments: $24,422